Publicacions en col·laboració amb investigadors/es de Azienda Ospedaliero Universitaria di Sassari (3)

2024

  1. European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)

    European Journal of Cancer, Vol. 204

2023

  1. Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

    European Journal of Cancer, Vol. 185, pp. 28-39

2022

  1. First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

    Cancer Chemotherapy and Pharmacology, Vol. 89, Núm. 4, pp. 499-514